Ohana Biosciences Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 59

Employees

  • Latest Deal Type
  • Out of Business

Ohana Biosciences General Information

Description

Developer of molecular techniques designed to create a novel category of fertility treatment. The company's techniques are used to improve reproductive health by focusing on sperm rather than egg biology, enabling patients to improve fertility rates, deliver non-hormonal contraception and reduce pregnancy complications.

Contact Information

Formerly Known As
VL34
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 20 Acorn Park Drive
  • Suite 301
  • Cambridge, MA 02140
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 20 Acorn Park Drive
  • Suite 301
  • Cambridge, MA 02140
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ohana Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 28-Apr-2021 Completed Out of Business
2. Early Stage VC (Series B) 01-Mar-2019 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Aug-2016 $15.1M $15.1M Completed Startup
To view Ohana Biosciences’s complete valuation and funding history, request access »

Ohana Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Ohana Biosciences’s complete cap table history, request access »

Ohana Biosciences Patents

Ohana Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210063381-A1 Methods for screening sperm for assisted reproduction Inactive 04-Sep-2019
EP-3817675-A1 Compositions and methods for enhancing sperm function Inactive 30-Nov-2018
EP-3817675-A4 Compositions and methods for enhancing sperm function Inactive 30-Nov-2018
US-10603075-B1 Compositions and methods for enhancing sperm function Inactive 30-Nov-2018
US-20200170674-A1 Compositions and methods for enhancing sperm function Inactive 30-Nov-2018 A61B17/43
To view Ohana Biosciences’s complete patent history, request access »

Ohana Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ohana Biosciences FAQs

  • When was Ohana Biosciences founded?

    Ohana Biosciences was founded in 2015.

  • Where is Ohana Biosciences headquartered?

    Ohana Biosciences is headquartered in Cambridge, MA.

  • What is the size of Ohana Biosciences?

    Ohana Biosciences has 59 total employees.

  • What industry is Ohana Biosciences in?

    Ohana Biosciences’s primary industry is Biotechnology.

  • Is Ohana Biosciences a private or public company?

    Ohana Biosciences is a Private company.

  • What is Ohana Biosciences’s current revenue?

    The current revenue for Ohana Biosciences is .

  • How much funding has Ohana Biosciences raised over time?

    Ohana Biosciences has raised $65.1M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process